GABA is the main inhibitory neurotransmitter in the mammalian brain. The postsynaptic GABA A receptor/pore complex is presumed to be a pentamer typically composed of a combination of ␣, ␤, and ␥ subunits, although the stoichiometry remains controversial. We probed the stoichiometry of the GABA A receptor by site-directed mutagenesis of a conserved leucine (to serine) in the putative second membrane-spanning domain of the rat ␣1(␣L263S), ␤2(␣L259S), and ␥2(␣L274S) subunit isoforms. Coexpression of wild-type and mutant subunits of each class (e.g., ␣ and ␣L263S), along with their wild-type counterparts (e.g., ␤ and ␥), in Xenopus laevis oocytes resulted in mixed populations of receptors with distinct GABA sensitivities. This is consistent with the interpretation that the leucine mutation increased the GABA sensitivity in proportion to the number of incorporated mutant subunits. The apparent number of incorporated subunits for each class (␣, ␤, and ␥) could then be determined from the number of components comprising the compound GABA dose-response relationships. Using this approach, we conclude that the recombinant ␣1␤2␥2 GABA A receptor is a pentamer composed of two ␣ subunits, two ␤ subunits, and one ␥ subunit.
The release of GABA from presynaptic nerve terminals in the CNS inhibits the postsynaptic neuron by gating a chlorideselective ion pore that is an integral component of the receptor complex. Four different classes of GABA A receptor subunits have thus far been identified in the mammalian brain: ␣, ␤, ␥, and ␦ (Schofield et al., 1987; Khrestchatisky et al., 1989; Lolait et al., 1989; Shivers et al., 1989; Ymer et al., 1989; Harvey et al., 1993) . In addition, multiple isoforms have been isolated for each of the ␣, ␤, and ␥ subunit classes. Exogenous expression of various combinations of subunits suggests that GABA A receptors must contain ␣, ␤, and ␥ subunits to reconstitute the major features of native GABA A receptors (Levitan et al., 1988; Pritchett et al., 1989; Malherbe et al., 1990; Sigel et al., 1990; Verdoorn et al., 1990) . Although structure-function studies of recombinant receptors have elucidated subunit domains and residues critical for activation and modulation (Pritchett and Seeburg, 1991; Sigel et al., 1992; Wieland et al., 1992; Amin and Weiss, 1993) , the stoichiometry of the GABA A receptor has been elusive.
Mutation of a conserved leucine in the putative second membrane-spanning domain of homomeric neuronal nicotinic acetylcholine (nACh) and serotonin type 3 (5-HT 3 ) receptors induced an increase in agonist sensitivity (Revah et al., 1991; Yakel et al., 1993) . (nACh and 5-HT 3 receptors are members of the same ligand-operated ion channel superfamily as the GABA A receptor.) More recent studies of heteromeric nACh receptors determined that each subunit of the receptor complex carrying this leucine mutation contributed an Ϸ10-fold increase in ACh sensitivity (Filatov and White, 1995; Labarca et al., 1995) .
We have used this leucine mutation to infer the number of each subunit type that comprises recombinant ␣1␤2␥2 GABA receptors expressed in Xenopus oocytes. Mutation of this leucine to serine in either the rat ␣1, ␤2, or ␥2 GABA subunit isoforms increased the sensitivity to GABA. Coexpression of wild-type and mutant subunits of each class (e.g., ␣ and ␣-mutant), along with their wild-type counterparts (e.g., ␤ and ␥), resulted in mixed populations of receptors with distinct GABA sensitivities. We were then able to infer the number of each subunit type from the number of components comprising these compound GABA doseresponse relationships. Using this approach, we conclude that the ␣1␤2␥2 GABA receptor is a pentamer composed of two ␣ subunits, two ␤ subunits, and one ␥ subunit.
MATERIALS AND METHODS
Site-directed mutagenesis and in vitro transcription. The cDNAs were isolated by the PCR (Saiki et al., 1988) as described previously (Amin et al., 1994) . The cDNAs were cloned into the pALTER vector for oligonucleotide-mediated site-directed mutagenesis using Altered Sites (Promega, Madison WI). The oligonucleotides (complementary to the sense strand) used to make the leucine to serine substitutions were ␣1(L263S): 5Ј-CAA GGT TGT CAT GGT ACT AAC GGT CGT CAC TCC-3Ј; ␤2(L259S): 5Ј-GAT TGT GGT CAT CGT ACT GAC AGT TGT AAT TCC-3Ј; and ␥2(L274S): 5Ј-GAG AGT GGT CAT CGT ACT GAC AGT CGT GAT TCC-3Ј. The mismatched base pairs are indicated in bold. Successful mutagenesis was confirmed by sequencing (Sanger et al., 1977) . cDNAs were linearized with SspI, which leaves a several hundred base pair tail that may increase cRNA stability in the oocyte. cRNA was transcribed from the linearized cDNAs by standard in vitro transcription procedures. Methods used to match the cRNA concentrations of the three subunits have been described previously (Amin and Weiss, 1996) .
Oocyte injection. Xenopus laevis (Xenopus I, Ann Arbor, MI) were anesthetized by hypothermia, and ovarian lobes were surgically removed from the frog and placed in a solution that consisted of (in mM): 82.5 NaCl, 2.5 KCl, 10 HEPES, 2 CaCl 2 , 1 MgCl 2 , and 10 Na 2 HPO 4 , 50 U/ml penicillin, and 50 g/ml streptomycin, pH 7.5. Oocytes were dispersed in this same solution minus CaCl 2 plus 0.3% Collagenase A (Boehringer Mannheim, Indianapolis, IN). After isolation, the oocytes were rinsed thoroughly. Stage VI oocytes were separated and maintained overnight at 18ЊC.
Micropipettes for injecting cRNA were fabricated on a Sutter P87 horizontal puller, and the tips were cut off with microscissors. The wild-type and mutant cRNAs were then mixed at the desired ratios and diluted with diethyl pyrocarbonate-treated water. Except for the experiments presented in Figure 5 , the ␣:␤:␥ cRNA injection ratio was always 1:1:1. The cRNA mixture was then drawn up into the micropipette and injected with the Nanoject injector (Drummond Scientific, Broomall, PA).
Electrophysiological recording. One to three days after injection, oocytes were placed on a 300 m nylon mesh suspended in a small volume chamber (Ͻ100 l). The chamber and perfusion system, which allows up to 18 different solutions to be introduced to an individual oocyte, has been described previously (Amin et al., 1994) . The oocyte was perfused continuously with a solution that consisted of (in mM): 92.5 NaCl, 2.5 KCl, 10 HEPES, 2 CaCl 2 , and 1 MgCl 2 , pH 7.5, and briefly switched to the test solution containing GABA.
Recording microelectrodes were fabricated with a P87 Sutter horizontal puller and filled with 3 M KCl. They had resistances of 1-3 M⍀. Standard two-electrode voltage-clamp techniques were used to record currents in response to the application of GABA. In all cases, the membrane potential was clamped to Ϫ70 mV. Data were played out on a chart recorder during the experiment and recorded on tape for off-line analysis.
Peak current amplitudes were measured directly from the chart record or from the computer screen. To quantify the agonist sensitivity, each dose-response relationship was fitted with the following equation using a nonlinear least-squares method:
where x is the number of fitted components and can vary from 1 to 3, I is the peak current at a given concentration of GABA (A), I max is the maximum current, EC 50 is the concentration of GABA yielding a current half the maximum, and n is the Hill coefficient.
RESULTS
Mutation of the conserved leucine in ␣1, ␤2, or ␥2 increases the GABA sensitivity The isoforms ␣1, ␤2, and ␥2 are widely distributed in the brain (Benke et al., 1991; Wisden et al., 1992; Ruano et al., 1994) , so we selected the ␣1␤2␥2 combination for this particular study. Given the remarkable sequence homology between isoforms within a class, the conclusions we reach will likely apply to recombinant GABA receptors composed of other ␣, ␤, and ␥ isoforms. In this manuscript, we designate the rat ␣1, ␤2, and ␥2 subunit isoforms as simply ␣, ␤, and ␥. A conserved leucine in the putative second membranespanning domain (TM2) was mutated to serine in the ␣ (␣L263S), ␤ (␤L259S), and ␥ (␥L274S) subunits. (Henceforth, the subunits with the leucine mutation will be designated ␣ m , ␤ m , and ␥ m ). cRNA was in vitro transcribed for both mutant and wild-type ␣, ␤, and ␥ subunits, mixed in the combinations ␣␤␥, ␣ m ␤␥, ␣␤ m ␥, and ␣␤␥ m , and injected into Xenopus laevis oocytes. Figure 1 A shows examples of GABA-activated currents from each of the four combinations of subunits. Note that much lower concentrations of GABA were required to activate the GABA receptors containing either an ␣ m , ␤ m , or ␥ m subunit. Figure 1B shows average GABA dose-response relationships for all four subunit combinations and illustrates the leftward shifts in the GABA dose-response relationships induced by the leucine to serine substitutions. The continuous lines are the best fits of the Hill equation to the data. The EC 50 values (concentration of GABA required for halfmaximal activation) determined from the fits were (mean Ϯ SD) ␣␤␥, 45.8 Ϯ 3.6 M; ␣ m ␤␥, 0.30 Ϯ 0.13 M; ␣␤ m ␥, 0.035 Ϯ 0.004 M; and ␣␤␥ m , 0.99 Ϯ 0.23 M.
Studies of heteromeric nACh receptors, in which the stoichiometry has been established (Reynolds and Karlin, 1978; Lindstrom et al., 1979; Raftery et al., 1980) , concluded that each subunit of the receptor complex carrying this leucine mutation contributed an Ϸ10-fold increase in ACh sensitivity (Filatov and White, 1995; Labarca et al., 1995) . For example, if two subunits in the nACh receptor complex are mutated, an Ϸ100-fold increase in ACh sensitivity was observed. In this study, we are attempting to work in the other direction; that is, infer the number of each subunit type comprising the GABA A receptor from the shift in GABA sensitivity induced by the mutations. The data presented in Figure 1 demonstrate a 153-, 1308-, and 46-fold decrease in the EC 50 with ␣ m , ␤ m , and ␥ m , respectively. Because the effects of the mutations may not be equivalent for ␣, ␤, and ␥ subunits, we could not ascertain directly the stoichiometry from these observed shifts in GABA sensitivity. Similarly, the shift in ACh sensitivity for the nACh receptor with one mutant subunit varied from 13-fold to 49-fold depending on which particular subunit (␣, ␤, ␥, or ␦) carried the mutation (Labarca et al., 1995) . We now describe a strategy to ascertain the stoichiometry that is not compromised by differences in the magnitude of the shifts induced by ␣ m , ␤ m , and ␥ m .
Coexpression of wild-type and mutant subunits Predictions
Assume there is only one ␣ subunit in the GABA A receptor complex. Coexpression of both ␣ and ␣ m subunits along with wild-type ␤ and ␥ subunits would result in GABA dose-response relationships having two components (Fig. 2 A) : one component from activation of the ␣ m ␤␥ receptors and one component from activation of the ␣␤␥ receptors. Furthermore, on the basis of the data presented in Figure 1 , the GABA EC 50 values of these two components would be Ϸ0.30 and Ϸ46 M, respectively. Alternatively, if the GABA receptor complex contained two ␣ subunits, the GABA dose-response relationships resulting from coexpression of ␣ m , ␣, ␤, and ␥ subunits would have three components ( ␣␣ m ␤␥ coexpression Figure 3A shows the results from experiments in which ␣ m , ␣, ␤, and ␥ subunits were all coexpressed in the same oocyte. The resulting dose-response relationship was well described by the sum of three Hill equations (continuous line (Fig. 2B ). Our interpretation of this intermediate component is that it represents the activation of receptors containing both an ␣ and an ␣ m subunit. This interpretation is supported by the experiment shown in the inset of Figure 3A . Oocytes were injected with ␣␤␥ cRNA; 5 d later, the same oocytes were injected with ␣ m ␤␥ cRNA. Previous studies demonstrate that the cRNA for glycine subunits (Kuhse et al., 1993) or GABA subunits (Amin and Weiss, 1996) injected into Xenopus oocytes is degraded within 2-3 d. Therefore, after the second injection, the oocytes should contain only ␣␤␥ and ␣ m ␤␥ receptors, and no intermediate component (attributable to ␣␣ m ␤␥ receptors) should be observed. This was indeed the case, because the dose-response relationship in these delayed-injection experiments was described by the sum of two Hill equations (continuous line) with EC 50 values of (mean Ϯ SD) 0.42 Ϯ 0.17 M and 30.0 Ϯ 7.5 M (n ϭ 3).
␣␤␤ m ␥ coexpression Figure 3B presents the average GABA dose-response relationship from oocytes coexpressing ␤ and ␤ m subunits along with wild-type ␣ and ␥ subunits. The continuous line in Figure 3B is the best fit of the sum of three Hill equations. The EC 50 of the first component, 0.025 Ϯ 0.01 M, corresponds to that determined with ␣␤ m ␥ coexpression (0.035 Ϯ 0.004 M), and the EC 50 of the third component, 39.2 Ϯ 7.9 M, corresponds to that of the ␣␤␥ receptor (45.8 Ϯ 3.6 M). Again, the presence of an intermediate component (EC 50 ϭ 0.94 Ϯ 0.07 M) indicates that the GABA receptor contains more than one ␤ subunit (Fig. 2B ). Assuming two ␤ subunits and the shift observed in Figure 1B for ␣␤ m ␥ coexpression (1308-fold), each ␤ m subunit would contribute a 36.2-fold increase in GABA sensitivity, predicting an intermediate EC 50 of 1.27 M. This is 
␣␤␥␥ m coexpression
The data presented thus far (Fig. 3A,B) suggest the presence of two ␣ subunits and two ␤ subunits. If, by analogy with other members of this receptor-operated super-family, we assume that the GABA A receptor is a pentameric complex (Langosch et al., 1988; Anand et al., 1991; Cooper et al., 1991; Unwin, 1993; Nayeem et al., 1994; Macdonald and Olsen, 1994) , we can assume there is only one ␥ subunit. This inferred presence of one ␥ subunit is confirmed by the ␣␤␥␥ m coexpression studies presented in Figure 3C . In contrast to that of ␣␣ m ␤␥ and ␣␤␤ m ␥ coexpression, the ␣␤␥␥ m dose-response relationships were described by the sum of only two Hill equations (continuous line). Furthermore, the EC 50 of the first component, 1.09 Ϯ 0.12 M, corresponds to that determined with ␣␤␥ m coexpression (0.99 Ϯ 0.23), and the EC 50 of the second component, 40.9 Ϯ 4.8 M, corresponds to that determined for ␣␤␥ receptors (45.8 Ϯ 3.6 M). Therefore, the two components in Figure 3C represent the activation of receptors containing either a ␥ or ␥ m subunit, and the GABA receptor complex contains only one ␥ subunit.
Varying the ratio of wild-type and mutant subunits
We next considered the possibility that there are multiple indistinguishable intermediate components in the dose-response relationships of Figure 3 . To address this issue, the ratio of wild-type and mutant cRNA (e.g., ␣ and ␣ m ) coinjected with their wild-type counterparts (e.g., ␤ and ␥) was varied. At all cRNA injection ratios tested, the GABA dose-response relationships consisted of three components for ␣␣ m ␤␥ and ␣␤␤ m ␥ coexpression and two components for ␣␤␥␥ m coexpression. Figure 4 presents plots of the EC 50 values versus the fraction of the wild-type component for each of the three coexpression experiments. The fraction of the wild-type component is the amplitude of the wild-type component divided by the total amplitude and is determined from the fits to the individual compound dose-response relationships. The EC 50 values and component fractions are presented in Table 1 . The relative fraction of the components varied in a manner that would be expected for the different cRNA injection ratios; that is, the amplitude of the wild-type component increased with an increase in the ratio of ␣-to-␣ m cRNA. Figure 4A is a plot of the EC 50 values of the three components versus the fraction of the wild-type component for ␣␣ m ␤␥ coexpression. The dashed lines represent the mean EC 50 determined from expression of ␣␤␥ and ␣ m ␤␥ (Fig. 1B) . The EC 50 values of the first and third components do not depend on the relative proportions of the different receptor combinations consistent with the interpretation that they represent the activation of receptors containing all mutant and all wild-type ␣ subunits, respectively. The continuous line is from a linear regression to the EC 50 of the intermediate component and demonstrates a very slight, but significant ( p Ͻ 0.05), negative dependence on the fraction of the wild-type component. That is, the EC 50 decreased slightly with increasing availability of the wild-type ␣ subunit. If the intermediate component was the combination of more than one subcomponent, the expected relationship should be in the opposite direction than that observed; that is, the EC 50 should increase with an increase in the fraction of the wild-type component. The slight decrease in the EC 50 with increasing fraction of the wild-type component may reflect differences in the ability to extract the EC 50 values from these compound dose-response relationships as the amplitudes of the components vary. Figure  4B ,C are similar plots of the EC 50 values as a function of the fraction of the wild-type component with ␣␤␤ m ␥ and ␣␤␥␥ m coexpression. In both cases, the EC 50 values of all components appeared independent of the component amplitudes (Table 1) . The amplitudes of the components in these wild-type and mutant coexpression experiments did not correspond in all cases to that predicted by the binomial hypothesis. Possible explanations for this discrepancy will be considered in the Discussion.
Nevertheless, the data presented in Figure 4 suggest that in terms of GABA sensitivity, there are three receptor types with ␣␣ m ␤␥ and ␣␤␤ m ␥ coexpression and two receptor types with ␣␤␥␥ m coexpression, further supporting a pentameric GABA A receptor composed of two ␣ subunits, two ␤ subunits, and one ␥ subunit.
The stoichiometry does not depend on the relative availability of ␣, ␤, and ␥ subunits Finally, we considered whether the stoichiometry of the GABA receptor is fixed or can vary, depending on the relative abundance of the different subunit types. To address this issue, we injected ␣ m , ␤, and ␥ cRNA at a ratio of 4:1:1 or ␣, ␤, and ␥ m cRNA at a ratio of 1:1:4. If the increased availability of ␣ or ␥ subunits can increase the number of ␣ or ␥ subunits incorporated into the GABA receptor, the EC 50 values should shift further to the left than that observed with equivalent cRNA injection ratios (Fig.  1B) . The results from these experiments are presented in Figure  5 . For both cases, the EC 50 values of the GABA dose-response relationships with nonequivalent injection ratios were indistinguishable from those determined with equivalent cRNA injection ratios. These data indicate that at least at these cRNA ratios, the number of ␣ and ␥ subunits in the GABA receptor is fixed. By default, the number of ␤ subunits should be fixed as well.
DISCUSSION

Summary, assumptions, and limitations
By taking advantage of a mutation in the putative second membrane-spanning domain of the GABA A receptor subunits that increased the GABA sensitivity in relative proportion to the number of subunits carrying the mutation, we were able to infer that recombinant ␣1␤2␥2 receptors are pentamers composed of two ␣ subunits, two ␤ subunits, and one ␥ subunit. We have also demonstrated that at least over a fourfold ratio of injected cRNA concentrations, the stoichiometry appears to be fixed. Behe et al. (1995) used a similar strategy of wild-type and mutant subunit coexpression to determine the number of incorporated NR1 sub- Values are mean Ϯ SD. In all cases, total ␣:␤:␥ cRNA ratios were 1:1:1.
units in recombinant N-methyl-D-aspartate (NMDA) receptors, although their approach differs from the present study in that they relied on mutation-induced alterations in the single-channel conductance.
Our conclusions are tied strongly to the assumption that the mutations do not alter the normal stoichiometry of the ␣1␤2␥2 GABA A receptor. Although we have no direct evidence, it seems unlikely that a point mutation in a residue that is presumed to face the interior of the pore (Revah et al., 1991; Unwin, 1995; Xu and Akabas, 1996) would so drastically affect subunit-subunit interactions as to induce an atypical stoichiometry. We have also assumed that the different possible subunit arrangements of the A, Plot of the EC 50 values of the three components as a function of the fraction of the wild-type component for ␣␣ m ␤␥ coexpression. The fraction of the wild-type component is the amplitude of the wild-type component divided by the total amplitude and is determined from the fits to the individual compound dose-response relationships. In these experiments, GABA dose-response relationships were constructed from oocytes in which the ␣-to-␣ m cRNA injection ratio was varied (1:3, 1:1, and 3:1) to shift the relative amplitudes of the different components. The total amount of ␣ and ␣ m cRNA remained fixed with respect to ␤ and ␥. For all ␣-to-␣ m ratios tested, the GABA dose-response relationships were described by the sum of three Hill equations. The dashed lines represent the mean EC 50 values determined from ␣␤␥ and ␣ m ␤␥ coexpression (Fig. 1) . The continuous line is a linear regression to the EC 50 of the intermediate component and demonstrates a slight but significant ( p Ͻ 0.05) negative dependence that is in the opposite direction from that predicted if there were multiple, indistinguishable, intermediate components (see text). These data indicate three components and hence two ␣ subunits in the GABA receptor complex. B, Similar plot as in A, but for ␣␤␤ m ␥ coexpression at different ratios of ␤ to ␤ m (1:1 and 3:1). The dashed lines represent the mean EC 50 values determined from ␣␤␥ and ␣␤ m ␥ coexpression (Fig. 1) . These data indicate three components and hence two ␤ subunits in the GABA receptor complex. C, Similar plot as in A, but for ␣␤␥␥ m coexpression at different ratios of ␥ to ␥ m (1:3 and 1:1). These data indicate two components and hence one ␥ subunit in the GABA receptor complex. mutant and wild-type subunits within the pentameric complex are functionally equivalent.
To uncover any possible hidden components in the compound dose-response relationships of Figure 3 , we varied the wild-typeto-mutant cRNA ratio for each of the subunits (e.g., ␣, ␣ m ) and coexpressed this mixture along with their wild-type counterparts (e.g., ␤, ␥). Although the relative amplitudes of the components depended on the wild-type-to-mutant cRNA ratio, the observed number of components and their EC 50 values were essentially independent of the cRNA ratio. This supports the conclusion that the dose-response relationships in Figure 3A -C are composed of only three, three, and two components, respectively.
We do not believe that the shifts in EC 50 in Figure 1 , and the additional components in Figure 2 , result from the expression of subpopulations of GABA receptors with different GABA sensitivities (e.g., ␣␤, ␤␥, etc.) for the following reasons. Amin et al., 1994) , which is less GABA-sensitive than any of the nonwild-type components (Figs. 2 and 3; Table 1 ). The observation that the EC 50 values do not shift with changes in the wild-type-to-mutant coinjection ratios ( Fig. 4; Table 1 ) further strengthens the conclusion that subpopulations of GABA receptors cannot account for the shifts in GABA sensitivity.
The amplitudes of the components for the different cRNA injection ratios deviated somewhat from that predicted by the binomial distribution. For example, at a wild-type-to-mutant cRNA ratio of 1:1 (Table 1) , the fractional amplitudes of the wild-type components were 0.72 Ϯ 0.07 (n ϭ 3), 0.27 Ϯ 0.07 (n ϭ 4), and 0.72 Ϯ 0.12 (n ϭ 3) for ␣␣ m ␤␥, ␣␤␤ m ␥, and ␣␤␥␥ m , respectively. Assuming that the percentages of the different receptor combinations were to follow a binomial distribution, the fraction of wild-type receptors should be 0.25 for ␣␣ m ␤␥ and ␣␤␤ m ␥ coexpression and 0.50 for ␣␤␥␥ m coexpression. Several factors could account for this discrepancy. First, the mutations may affect subunit assembly. If the mutant subunit does not assemble as efficiently as that of the wild type, the amplitudes of the components would deviate from those predicted by the binomial distribution. Second, if the mutation altered the maximum percent time open or the single-channel conductance, the relative amplitudes of the components would be altered accordingly. In fact, the mutations do affect the Hill coefficients slightly (see Fig.  1 legend) , suggesting an alteration in the gating kinetics. Third, the determination of the amplitudes of the components may be influenced by receptor desensitization. At high agonist concentrations, desensitization would diminish the relative contribution of the receptors in the more GABA-sensitive components, thus depressing the apparent amplitude of the wild-type component. Fourth, in the case of ␣ m ␤␥ and ␣␤ m ␥ coexpression, we observed a picrotoxin-sensitive current in the absence of GABA that was not observed in oocytes expressing ␣␤␥ m or ␣␤␥ receptors (data not shown). This may represent the spontaneous opening of GABA receptors with two mutant subunits incorporated. If so, this would alter the relative contributions of the components in the compound dose-response relationship with ␣␣ m ␤␥ and ␣␤␤ m ␥ coexpression. And finally, there may be slight errors in estimating the relative wild-type and mutant cRNA concentrations from the agarose gels. Although these factors could influence the estimation of the parameters in these compound doseresponse relationships, it is not apparent how they would alter the general conclusions from this study, which rely more heavily on a detection of the number of components. Moreover, our conclusions are strengthened by the excellent agreement between the observed and predicted EC 50 values of the components in Figures  3 and 4 .
Comparison with other studies
Our studies are consistent with evidence indicating that some native (Duggan et al., 1991; Luddens et al., 1991; Pollard et al., 1995) and recombinant (Verdoorn, 1994) GABA receptors can contain multiple subtypes of the ␣ subunit. In addition, Im et al. (1995) , using tandem constructs of ␣6-␤2 GABA subunits, concluded that ␣6␤2␥2 GABA receptors contain two ␣ subunits, two ␤ subunits, and one ␥ subunit.
Our results are in contrast to those of Benke et al. (1994) , which infer that only one ␤ subunit is present in the native GABA receptor. This conclusion was reached from the observation that [ 3 H]flumazenil or [ 3 H]muscimol binding to native GABA receptors immunoprecipitated from brain by ␤1, ␤2, or ␤3 antiserum sum to ϳ100% of the total binding. If neurons dominantly express one isoform of the ␤ subunit, however, the results of Benke et al. (1994) would be obtained regardless of the number of ␤ subunits in the GABA receptor complex. In fact, immunolocalization studies indicate some segregation of the ␤ subunit isoforms to different brain regions (Benke et al., 1994) . Quirk et al. (1994) observed that the sum of the percentages of [ 3 H]muscimol binding sites immunoprecipitated by ␥2 and ␥3 subunit antisera was slightly greater than the [ 3 H]muscimol binding observed with ␥2 and ␥3 antisera in combination, although as the authors report, the difference was within the limit of error of the measurement. Khan et al. (1994) made a similar observation using antibodies raised to ␥2S and ␥2L subunits. In both cases, the data were used to conclude that a minor fraction of the GABA receptors can contain more than one type of ␥ subunit. Further- Figure 5 . The stoichiometry does not depend on the ␣␤␥ cRNA injection ratio. The ␣ m ␤␥ and ␣␤␥ m cRNA combinations were injected into oocytes at ratios of 4:1:1 and 1:1:4, respectively. The GABA dose-response relationships were then fit by the Hill equation and compared with those determined with 1:1:1 cRNA injections. The EC 50 values of the GABA dose-response relationships for ␣ m ␤␥ cRNA ratios of 1:1:1 and 4:1:1 were (mean Ϯ SD) 0.30 Ϯ 0.13 M (n ϭ 9) and 0.30 Ϯ 0.04 M (n ϭ 5), respectively. The EC 50 values of the GABA dose-response relationships for ␣␤␥ m cRNA ratios of 1:1:1 and 1:1:4 were 0.99 Ϯ 0.23 M (n ϭ 4) and 0.98 Ϯ 0.062 M (n ϭ 4), respectively. These data indicate that at least at these cRNA ratios, the number of ␣ and ␥ subunits in the GABA receptor is fixed. more, GABA receptors obtained by ␥3 immunoprecipitation were labeled in a Western blot probed with ␥2 antisera, again suggesting that ␥2 and ␥3 subunits can coexist in the same GABA receptor complex. This conclusion seems to contradict our findings that the ␣1␤2␥2 GABA receptor contains a single copy of the ␥2 subunit. It should be kept in mind, however, that immunoprecipitation studies investigate total GABA or benzodiazepine binding to isolated membranes. This approach may include (1) a subpopulation of nonfunctional GABA receptors having an aberrant stoichiometry (our approach is limited to functional GABA A receptors) or (2) a subpopulation of ␤␥ or ␣␥ GABA receptors that may contain multiple ␥ subunits. It is also possible that GABA receptors may have a stoichiometry that depends on the expression system (neurons, transfected mammalian cells, oocytes) or the particular ␣, ␤, and ␥ subunit isoforms.
Finally, Backus et al. (1993) examined the stoichiometry of rat ␣3␤2␥2 receptors in transfected human embryonic kidney cells (HEK293) and concluded that the possible subunit stoichiometries for this receptor were 2␣1␤2␥, 2␣2␤1␥, or 1␣2␤2␥, of which 2␣1␤2␥ was favored. This study examined the degree of outward rectification induced by charged substitutions in homologous positions of the putative pore-forming domain of the ␣3, ␤2, and ␥2 subunit isoforms. As stated by the authors, the conclusions assumed that the degree of the effect of changing the charge on the outward rectification is the same for all the subunits. Given that the amino acid at one of the two mutated positions was not conserved across the three subunits (arginine, tyrosine, or lysine), this assumption may not hold true. Perhaps both conservative and nonconservative substitutions (in terms of charge) at these positions, along with wild-type and mutant coexpression of each subunit type, could be used to test this assumption.
Arrangement of the subunits
The question of the precise manner in which the two ␣ subunits, two ␤ subunits, and one ␥ subunit are arranged within the pentameric structure is still unanswered. Some insight may be provided by structure/function studies of the GABA A receptor. For example, site-directed mutagenesis has previously identified a residue on the ␣ subunit and two domains on the ␤ subunit that seem to form part of the GABA binding site (Sigel et al., 1992; Amin and Weiss, 1993) . If, as for the nACh receptor, the agonist binding sites are at subunit interfaces (Kurosaki et al., 1987; Blount and Merlie, 1989; Pedersen and Cohen, 1990; Czajkowski and Karlin, 1991; Sine and Claudio, 1991; Sine, 1993) , at least one of the two GABA binding sites may be at the ␣-␤ subunit interface (Smith and Olsen, 1995) . A detailed single-channel kinetic analysis (Sine and Steinbach, 1987; Colquhoun and Ogden, 1988; Weiss and Magleby, 1989; Twyman et al., 1990; Newland et al., 1991) may provide information on the equivalence of the two GABA binding sites and help place the second binding site at either the other ␣-␤ interface or at a ␤-␥ or ␣-␥ interface.
Although the potential subunit interactions underlying activation and modulation of GABA A receptors are yet to be elucidated, knowledge of the stoichiometry will facilitate the incorporation of the wealth of structural and functional information into a cohesive model of the GABA A receptor/pore complex.
